PLSE.O (PLSE.O) News
Follow PLSE.O (PLSE.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Pulse Biosciences completes patient enrollment for cardiac catheter study
Pulse Biosciences reached its enrollment target of 164 evaluable patients for the NANOPULSE-AF IDE pivotal study of its nPulse cardiac catheter system for atrial fibrillation.
EQUITY | Oct 07, 2026, 11:03 AM UTC
M
Pulse Biosciences NANOPULSE-AF Study reaches enrollment target
Pulse Biosciences announced its NANOPULSE-AF Study evaluating the nPulse™ Cardiac Catheter System has reached its enrollment target of 164 evaluable patients across 15 clinical sites. The study achieved enrollment three
EQUITY | Oct 07, 2026, 11:01 AM UTC